Clinical Outcomes of Percutaneous Coronary Intervention Using Excimer Laser Coronary Atherectomy for Complex Coronary Lesions: The ACCELERATE Registry
- PMID: 40588859
- DOI: 10.1002/ccd.31739
Clinical Outcomes of Percutaneous Coronary Intervention Using Excimer Laser Coronary Atherectomy for Complex Coronary Lesions: The ACCELERATE Registry
Abstract
Background: Excimer laser coronary atherectomy (ELCA) is a technology used to treat a wide spectrum of complex coronary lesions, such as thrombotic lesions, severe calcific lesions, non-crossable or non-expandable lesions, chronic total occlusions, stent under-expansion, and stent restenosis.
Aims and methods: This prospective multicenter observational study aims at examining procedural, in-hospital and long-term clinical outcomes in a consecutive cohort of patients treated with ELCA for complex coronary lesions. The primary end point was the rate of procedural success, defined as PCI success plus the absence of in-hospital MACE.
Results: From July 2018 to May 2024 a total of 320 consecutive patients (age 71 ± 9 years) with 429 lesions treated with ELCA were enrolled. The most common clinical presentation was chronic coronary syndrome (48%), and the left anterior descending artery was the target vessel in 47% of cases. The subsets of lesions treated were stent restenosis (48%), de novo lesions (46%), and stent underexpansion (6%). Procedural success was achieved in 97% of patients. In-hospital MACE occurred in 1.2% of cases, mainly driven by death (0.9%) and no reflow (0.9%). After multivariate analysis, left ventricular function was recognized as independent predictor of procedural failure (OR 0.9, 95% CI 0.84-0.97, p = 0.006). During a median clinical follow-up of 841 days (interquartile range: 395-1414) the survival free from MACE was 94.7%. Death was 2.9%, MI 1.5%, TLR 3.4%, and the composite was 4.7%.
Conclusion: ELCA demonstrates a high rate of angiographic and clinical success in treating complex coronary lesions in a real-world cohort of high-risk patients.
Keywords: ELCA; PCI; calcified lesion.
© 2025 Wiley Periodicals LLC.
References
-
- Y. E. A. Appelman, J. J. Piek, G. K. David, et al., “Randomised Trial of Excimer Laser Angioplasty Versus Balloon Angioplasty for Treatment of Obstructive Coronary Artery Disease,” Lancet 347 (1996): 79–84, https://doi.org/10.1016/s0140-6736(96)90209-3.
-
- N. Reifart, M. Vandormael, M. Krajcar, et al., “Randomized Comparison of Angioplasty of Complex Coronary Lesions at a Single Center. Excimer Laser, Rotational Atherectomy, and Balloon Angioplasty Comparison (ERBAC) Study,” Circulation 96 (1997): 91–98, https://doi.org/10.1161/01.cir.96.1.91.
-
- L. Bilodeau, E. B. Fretz, Y. Taeymans, J. Koolen, K. Taylor, and D. J. Hilton, “Novel Use of a High‐Energy Excimer Laser Catheter for Calcified and Complex Coronary Artery Lesions,” Catheterization and Cardiovascular Interventions 62 (2004): 155–161, https://doi.org/10.1002/ccd.20053.
-
- R. F. Riley, M. P. Patel, J. D. Abbott, et al., “SCAI Expert Consensus Statement on the Management of Calcified Coronary Lesions,” Journal of the Society for Cardiovascular Angiography & Interventions 3 (2024): 101259, https://doi.org/10.1016/j.jscai.2023.101259.
-
- T. G. van Leeuwen, J. H. Meertens, E. Velema, M. J. Post, and C. Borst, “Intraluminal Vapor Bubble Induced by Excimer Laser Pulse Causes Microsecond Arterial Dilation and Invagination Leading to Extensive Wall Damage in the Rabbit,” Circulation 87 (1993): 1258–1263, https://doi.org/10.1161/01.cir.87.4.1258.